John Wiley & Sons, Inc. (NYSE:WLYB – Get Free Report) hit a new 52-week high on Tuesday . The stock traded as high as $48.19 and last traded at $48.19, with a volume of 9 shares changing hands. The stock had previously closed at $48.19.
John Wiley & Sons Price Performance
The company’s fifty day moving average is $40.76 and its two-hundred day moving average is $37.48. The firm has a market capitalization of $2.62 billion, a price-to-earnings ratio of -13.24 and a beta of 0.70. The company has a quick ratio of 0.49, a current ratio of 0.52 and a debt-to-equity ratio of 1.04.
John Wiley & Sons (NYSE:WLYB – Get Free Report) last posted its earnings results on Thursday, June 13th. The company reported $1.21 earnings per share for the quarter. The company had revenue of $468.46 million for the quarter. John Wiley & Sons had a negative net margin of 10.69% and a positive return on equity of 18.82%.
John Wiley & Sons Increases Dividend
Institutional Investors Weigh In On John Wiley & Sons
An institutional investor recently bought a new position in John Wiley & Sons stock. PFG Investments LLC acquired a new position in shares of John Wiley & Sons, Inc. (NYSE:WLYB – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 53,477 shares of the company’s stock, valued at approximately $2,033,000. PFG Investments LLC owned approximately 0.10% of John Wiley & Sons as of its most recent SEC filing. Institutional investors and hedge funds own 0.49% of the company’s stock.
John Wiley & Sons Company Profile
John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.
See Also
- Five stocks we like better than John Wiley & Sons
- 3 Warren Buffett Stocks to Buy Now
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- Investing In Preferred Stock vs. Common Stock
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with MarketBeat.com's FREE daily email newsletter.